Key Record Dates
ClinicalTrials.gov Identifier: | NCT02433795 |
---|---|
Brief Title: | Bendamustine Plus Rituximab (BR) for Relapsed or Progressive Marginal Zone B-cell Lymphoma (MZBCL) |
First Submitted : | April 5, 2015 |
First Submitted that Met QC Criteria : | May 4, 2015 |
First Posted : | May 5, 2015 (Estimate) |
Last Update Submitted that Met QC Criteria : | December 1, 2020 |
Last Update Posted : | December 3, 2020 |